Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models

Journal of Investigative Dermatology

Volumn 118, Issue 1, 2002, Pages 94-101

  Sheu, Mary Y ^a   Fowler, Ashley J ^a   Kao, Jack ^a   Schmuth, Matthias ^a   Schoonjans, Kristina ^a,b   Auwerx, Johan ^a,b   Fluhr, Joachim W ^a   Man, Mao Qiang ^a   Elias, Peter M ^a   Feingold, Kenneth R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Clofibrate; Epidermis; Nuclear hormone receptors

Indexed keywords

CLOBETASOL; CLOFIBRATE; INTERLEUKIN 1ALPHA; LINOLEIC ACID; OXAZOLONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PIRINIXIC ACID; STEARIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; EAR; EPIDERMIS; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN INFLAMMATION; TISSUE LEVEL;

EID: 0036153739     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01626.x     Document Type: Article

References (38)

1. Glucocorticoids in T cell development and function
2. NF-kappa B: Ten years after
3. 1,25(OH)2D3-modulated calcium induced keratinocyte differentiation
4. Peroxisome proliferator-activated receptor-alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP- 1
5. Induction of IkBa expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators
6. The PPAR-alpha-leukotriene B4 pathway to inflammation control
7. Effects of long-term retinoic acid treatment on epidermal differentiation in vivo, specific modification in the programme of terminal differentiation
8. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation
9. Molecular mechanisms of retinoid actions in skin
10. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
11. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
12. Activators of the nuclear hormone receptors PPAR-alpha and FXR accelerate the development of the fetal epidermal permeability barrier
13. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor peroxisome proliferator-activated receptor-α
14. Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators
15. Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription
16. Effect of peroxisome proliferator-activated receptor-alpha activators on tumor necrosis factor expression in mice during endotoxemia
17. Roles of PPAR in health and disease
18. Orphan nuclear receptors: Shifting endocrinology into reverse
19. Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs
20. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development
21. Stimulation of peroxisome proliferator-activated receptor-α promotes epidermal keratinocyte differentiation in vivo
22. Keratinocyte differentiation in hyperproliferative epidermis. Topical application of peroxisome proliferator-activated receptor-̈ activators restores tissue homeostasis
23. Allergic and immunologic skin disorders
24. The RXR heterodimers and orphan receptors
25. The nuclear receptor superfamily: The second decade
26. PPAR-alpha activators inhibit cytokine-induced vascular cell adhesion molecule- 1 expression in human endothelial cells
27. Interleukin- 1 and cutaneous inflammation. A crucial link between innate and acquired immunity
28. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta)
29. TNF and the pathology of the skin
30. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
31. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of keratinocytes
32. Peroxisome proliferator-activated receptor-α enhances lipid metabolism in a skin equivalent model
33. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
34. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
35. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease
36. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
37. Activation of human aortic smooth-muscle cells is inhibited by PPAR-alpha but not by PPARgamma activators
38. Allergic contact dermatitis